GlassScriptPhysician profile
Mahmood Omran Dweik
NPI 1245228741
$4,403.75
in general payments reported to CMS, 2019-2025
11 companies · $2,012 in 2025
The $2,012 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $42.37 · 2021: $635 · 2022: $645 · 2023: $361 · 2024: $222 · 2025: $2,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,497 · Travel and Lodging: $1,032 · Education: $67.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,496.69 |
| Travel and Lodging | $1,031.71 |
| Education | $67.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,038.83 | 2023-2025 | Inspire |
| Abbott Laboratories | $1,183.38 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $562.73 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $215.60 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $124.14 | 2024 | Prolaris |
| Itamar Medical INC | $104.83 | 2024-2025 | Watchpatone |
| Axsome Therapeutics, INC. | $68.66 | 2025 | Sunosi |
| Harmony Biosciences LLC | $46.52 | 2024 | |
| Genentech USA, INC. | $23.57 | 2019 | |
| Apria Healthcare LLC | $20.75 | 2021 | |
| Amgen INC. | $14.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahmood Dweik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.